Scarica l'app Stockscreener
187.58
0.39%
0.73
Dopo l'orario di chiusura:
187.58
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$186.85
Aprire:
$185.6
Volume 24 ore:
1.41M
Relative Volume:
1.51
Capitalizzazione di mercato:
$20.98B
Reddito:
$10.52B
Utile/perdita netta:
$999.00M
Rapporto P/E:
22.43
EPS:
8.3628
Flusso di cassa netto:
$1.22B
1 W Prestazione:
+6.27%
1M Prestazione:
+2.63%
6M Prestazione:
+7.50%
1 anno Prestazione:
+16.84%
Intervallo 1D:
$184.50
$190.47
Intervallo di 1 settimana:
$175.76
$191.31
Portata 52W:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Nome
Quest Diagnostics Inc
Settore
Industria
Telefono
(973) 520-2700
Indirizzo
500 PLAZA DRIVE, SECAUCUS
Confronta DGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
187.58 | 20.79B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
580.13 | 220.92B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.20 | 154.97B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.48 | 56.98B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.89 | 42.96B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
223.55 | 37.62B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | Iniziato | Redburn Atlantic | Buy |
| 2025-03-04 | Downgrade | Citigroup | Buy → Neutral |
| 2025-01-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | Ripresa | Jefferies | Buy |
| 2024-10-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | Ripresa | Evercore ISI | In-line |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-02-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-06-29 | Iniziato | Piper Sandler | Neutral |
| 2023-05-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-01-23 | Iniziato | Evercore ISI | In-line |
| 2022-11-17 | Downgrade | Citigroup | Neutral → Sell |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2022-02-23 | Downgrade | UBS | Buy → Neutral |
| 2022-02-02 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-04 | Aggiornamento | UBS | Neutral → Buy |
| 2021-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | Aggiornamento | Argus | Hold → Buy |
| 2020-07-29 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-09 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-04-28 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-04-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | Downgrade | Goldman | Neutral → Sell |
| 2019-04-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-03-18 | Ripresa | Credit Suisse | Neutral |
| 2019-01-31 | Downgrade | Argus | Buy → Hold |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2019-01-03 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | Downgrade | Goldman | Buy → Neutral |
Mostra tutto
Quest Diagnostics Inc Borsa (DGX) Ultime notizie
Will Quest Diagnostics Incorporated stock gain from lower inflationJuly 2025 Final Week & Community Consensus Stock Picks - newser.com
Is Quest Diagnostics Incorporated stock nearing a technical breakoutJuly 2025 Sector Moves & Fast Entry and Exit Trade Plans - newser.com
Using flow based indicators on Quest Diagnostics IncorporatedWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
3rd Circ. Says Quest Didn't Eavesdrop In Data Privacy Suit - Law360
Will Quest Diagnostics Incorporated (QDI) stock beat international competitionJuly 2025 Levels & Reliable Momentum Entry Alerts - newser.com
Quest Diagnostics Incorporated stock trend forecastTrade Volume Summary & Growth Focused Stock Reports - newser.com
How to build a dashboard for Quest Diagnostics Incorporated stockWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com
Is Quest Diagnostics Incorporated (QDI) stock positioned for secular growthJuly 2025 Sentiment & AI Based Buy/Sell Signal Reports - newser.com
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Quest Diagnostics Solidifies Shareholder Value with $0.80 Quarterly Dividend - Markets Financial Content
Quest Diagnostics (NYSE: DGX) Bolsters Shareholder Confidence with Latest Dividend Declaration - Markets Financial Content
Quest Diagnostics Incorporated Declares Quarterly Cash Dividend, Payable on January 28, 2026 - MarketScreener
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics Keeps Quarterly Dividend at $0.80 a Share, Payable Jan. 28, 2026, to Holders of Record Jan. 13 - MarketScreener
Quest Diagnostics declares quarterly cash dividend of $0.80 By Investing.com - Investing.com Canada
Quest Diagnostics Declares Quarterly Cash Dividend - MarketScreener
Quest Diagnostics Declares Quarterly Cash Dividend - Benzinga
Quest Diagnostics (DGX) is a Top-Ranked Growth Stock: Should You Buy? - sharewise.com
Why Quest Diagnostics Incorporated stock is favored by top institutionsJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com
DGX SEC FilingsQuest Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What Fibonacci levels say about Quest Diagnostics Incorporated reboundWeekly Market Summary & Reliable Intraday Trade Alerts - newser.com
Published on: 2025-11-10 01:15:37 - newser.com
Published on: 2025-11-09 23:17:14 - newser.com
Quest Diagnostics Incorporated stock outlook for YEARTrade Entry Summary & Reliable Trade Execution Plans - newser.com
Why Quest Diagnostics Incorporated stock is a strong buy call2025 Price Momentum & Verified Trade Idea Suggestions - newser.com
Published on: 2025-11-08 11:00:37 - newser.com
[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan
How supply chain issues affect Quest Diagnostics Incorporated stock2025 Performance Recap & Real-Time Volume Analysis - newser.com
Is Quest Diagnostics Incorporated stock in correction or buying zonePortfolio Update Summary & Pattern Based Trade Signal System - newser.com
Can Quest Diagnostics Incorporated stock surprise with earnings upside2025 Earnings Impact & Technical Pattern Recognition Alerts - newser.com
Why Quest Diagnostics Incorporated stock is recommended by analystsJuly 2025 EndofMonth & Long Hold Capital Preservation Plans - Fundação Cultural do Pará
Why Quest Diagnostics Incorporated stock is favored by hedge fundsPortfolio Gains Report & Verified Stock Trade Ideas - newser.com
Can Quest Diagnostics Incorporated (QDI) stock deliver double digit returnsMarket Weekly Review & Stepwise Trade Execution Plans - Fundação Cultural do Pará
Forecasting Quest Diagnostics Incorporated price range with options dataRecession Risk & High Return Stock Watch Alerts - newser.com
Will Quest Diagnostics Incorporated (QDI) stock enhance shareholder valueJuly 2025 Trade Ideas & Growth Oriented Trading Recommendations - Fundação Cultural do Pará
Marion Wealth Management Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
TKG Advisors LLC Buys Shares of 6,484 Quest Diagnostics Incorporated $DGX - MarketBeat
State of Michigan Retirement System Sells 2,396 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Atria Investments Inc Purchases 2,599 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Is Quest Diagnostics Incorporated stock cheap compared to fundamentalsRisk Management & Community Consensus Stock Picks - newser.com
Quest Diagnostics Inc Azioni (DGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.70%
2.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):